AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
ResMed (ASX:RMD): Why Healthcare Shares Continue to Win Investor Confidence
April 28, 2025 12:49 PM AEST| By Team Kalkine MediaHighlights,ResMed (RMD),operates,a global healthcare business with expanding digital health capabilities.,Healthcare sector’s 'sticky' revenue offers resilience during economic downturns.,Growth and sustainability trends are boosting healthcare inves...
Setback for Telix Pharmaceuticals (ASX:TLX) as FDA Requests Additional Data for Brain Cancer Imaging Agent
April 28, 2025 12:48 PM AEST| By Team Kalkine MediaHighlights,FDA issues complete response letter for TLX101-CDx application,No safety concerns raised for investigational brain cancer imaging agent,Telix,Pharmaceuticals to pursue,additional,clinical strategies for resubmission,Telix Pharmaceuticals (...
FDA Setback Hits Telix Pharmaceuticals' Imaging Agent Ambitions
April 28, 2025 12:44 PM AEST| By Team Kalkine MediaHighlights,Telix,Pharmaceuticals faces FDA roadblock for glioma imaging agent,Additional,clinical data,required,for TLX101-CDx approval,Company's financial guidance,remains,unaffected,Telix Pharmaceuticals (ASX:TLX) encountered a major hurdle after t...
Recce Pharmaceuticals Strengthens Biodefense Strategy with New US Army Research Agreement
April 28, 2025 11:55 AM AEST| By Team Kalkine MediaHighlights,Recce Pharmaceuticals advances partnership with US Army.,R327 to be tested against deadly pathogens under high biocontainment.,Collaboration boosts efforts to combat antimicrobial resistance.,Recce Pharmaceuticals (ASX:RCE) has taken a sig...
Telix Faces Regulatory Setback as FDA Requests More Data on Brain Cancer Imaging Agent
April 28, 2025 11:54 AM AEST| By Team Kalkine MediaHighlights,Telix,faces regulatory setback on brain cancer imaging agent,FDA requests more clinical evidence for approval,Company plans swift resubmission after addressing feedback,Shares of Telix Pharmaceuticals (ASX:TLX) fell nearly 6% on Monday aft...
SomnoMed Limited (ASX:SOM): A Comprehensive Look at Recent Performance
April 26, 2025 12:30 PM AEST| By Team Kalkine MediaHighlights:,SomnoMed shares have seen a notable decline in recent weeks.,Despite recent challenges, the company has exhibited strong year-over-year growth.,The company's price-to-sales ratio reflects cautious investor sentiment.,SomnoMed Limited, lis...
Determining the Intrinsic Value of Alcidion Group Limited (ASX:ALC)
April 25, 2025 10:32 PM AEST| By Team Kalkine MediaHighlights:,Alcidion Group's share price closely reflects its estimated equity valuation derived from discounted cash flow modelling,The company maintains a debt-free structure with projected profitability supported by a strong cash position,Price-to...
Micro-X Insider Stock Buyers Recover Some Losses This Week
April 25, 2025 12:30 PM AEST| By Team Kalkine MediaHighlights:,Micro-X insiders hold a significant stake in the company, with a substantial portion of shares owned by those directly involved.,A noteworthy acquisition by Chairman Patrick O'Brien highlights confidence in the company's future.,Insider t...
Recce Pharmaceuticals Prepares for Pivotal Trials with A$15.8 Million Funding Injection
April 24, 2025 07:00 PM AEST| By Team Kalkine MediaHighlights,Recce Pharmaceuticals secures A$15.8 million for pivotal Phase 3 trials.,Key focus on diabetic foot infections and skin infections across Asia-Pacific and Australia.,US clinical plans advance with FDA submission in view for late 2025.,Recc...
ResMed’s (ASX:RMD) Robust Growth Driven by Demand for Sleep Apnoea Solutions
April 24, 2025 06:44 PM AEST| By Team Kalkine MediaHighlights,ResMed delivers strong double-digit EPS growth.,Robust demand for sleep apnoea devices drives revenue.,New home-based diagnostic test expands patient access.,ResMed (ASX:RMD), a global leader in digital health and sleep technology, has rep...
ASX Healthcare Focus: Exploring Cochlear Ltd (ASX:COH) Amid Sector Trends
April 24, 2025 06:26 PM AEST| By Team Kalkine MediaHighlights:,Cochlear Ltd has recorded a share price decline since the beginning of the year,The company manufactures hearing implants and operates in over fifty countries,Broader ASX healthcare sector has seen muted returns over the past several year...
ResMed (ASX:RMD) Reports Strong FY25 Q3 Performance Driving Share Price Surge
April 24, 2025 06:17 PM AEST| By Team Kalkine MediaHighlights:,ResMed’s revenue increased driven by performance across all major markets and product segments,Net profit recorded double-digit growth supported by expanded gross margins,Gross profit margin improved due to product mix and operational eff...
Botanix's SODFRA Sales Surge in Q1, Boosting Confidence in Expansion Strategy
April 24, 2025 06:12 PM AEST| By Team Kalkine MediaHighlights,Q1 revenue from SODFRA doubles between Feb and Mar,$40M raised via institutional placement,Expansion plans supported by strong cash reserves,Botanix Pharmaceuticals (ASX:BOT) has reported a strong commercial debut for its newly launched de...
Telix Pharmaceuticals: A Rapidly Growing Force in Cancer Treatment
April 24, 2025 06:12 PM AEST| By Team Kalkine MediaHighlights:,Telix Pharmaceuticals has experienced rapid revenue growth, reaching over one billion dollars in sales.,The company specializes in radiotherapy treatments for cancer, primarily marketed in the U.S.,Despite a notable rise in share value, e...
ResMed Navigates International Trade Policy with Tariff Exemption
April 24, 2025 01:30 PM AEST| By Team Kalkine MediaHighlights:,ResMed (ASX:RMD) secured a tariff exemption from the U.S. for products shipped from Australia and Singapore.,The exemption is tied to the Nairobi Protocol, which supports trade in products aiding individuals with disabilities.,Broader unc...
ResMed Soars on Robust Q3 Performance, Driven by Strong Product Demand and Margin Growth
April 24, 2025 11:39 AM AEST| By Team Kalkine MediaHighlights,ResMed reports 21% surge in quarterly earnings,Revenue hits US$1.29 billion on rising demand for sleep health devices,Gross margin expands to 59.3% on product mix and operational efficiency,ResMed (ASX:RMD) shares climbed over 8% to $35.99...
ResMed Secures Tariff Exemption, Boosts US Presence Amid Trade Tensions
April 24, 2025 10:53 AM AEST| By Team Kalkine MediaHighlights,ResMed receives exemption from US trade tariffs,Expands US manufacturing to manage policy uncertainty,Q3 revenue grows 8% to $US1.3 billion,Global sleep technology company ResMed (ASX:RMD) has announced that its products manufactured in Au...
Telix Pharmaceuticals Drives Growth Surge Among ASX Healthcare Stocks
April 23, 2025 04:55 PM AEST| By Team Kalkine MediaHighlights:,Telix Pharmaceuticals has expanded its revenues significantly within a few years, marking a sharp rise in commercial success.,The company has progressed from regulatory approvals to successful diagnostic and therapeutic product rollouts.,...
Cochlear Limited (ASX:COH) Navigates Market Pressures with Long-Term Resilience
April 23, 2025 04:33 PM AEST| By Team Kalkine MediaHighlights,Cochlear shares have declined in the recent quarter but maintain notable growth over an extended period,Shareholder return outpaces stock price gains due to consistent dividend contributions,Company records multiple senior-level stock acqu...
We Are Monitoring Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn Rate
April 23, 2025 04:32 PM AEST| By Team Kalkine MediaHighlights,Paradigm Biopharmaceuticals reported a significant year-on-year reduction in cash usage,Cash reserves remain above spending levels, offering a manageable funding horizon,Future capital requirements could lead to shareholder dilution if equ...
Advertise your brand on Kalkine Media